Pharmacological profile and efficiency in vivo of diflapolin, the first dual inhibitor of 5-lipoxygenase-activating protein and soluble epoxide hydrolase-Reference-Cited by-同舟云学术

Pharmacological profile and efficiency in vivo of diflapolin, the first dual inhibitor of 5-lipoxygenase-activating protein and soluble epoxide hydrolase

Published:2017-08-24 Issue:1 Volume:7 Page:
ISSN:2045-2322
Container-title:Scientific Reports
language:en
Short-container-title:Sci Rep

Author:

Garscha Ulrike,Romp Erik,Pace Simona,Rossi Antonietta,Temml Veronika,Schuster Daniela^ORCID,König Stefanie,Gerstmeier Jana,Liening Stefanie,Werner Markus,Atze Heiner,Wittmann Sandra,Weinigel Christina,Rummler Silke,Scriba Gerhard K.,Sautebin Lidia,Werz Oliver

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/s41598-017-09795-w.pdf

Reference67 articles.

1. Harizi, H., Corcuff, J. B. & Gualde, N. Arachidonic-acid-derived eicosanoids: roles in biology and immunopathology. Trends Mol Med 14, 461–469, doi: 10.1016/j.molmed.2008.08.005 (2008).

2. Haeggstrom, J. Z. & Funk, C. D. Lipoxygenase and leukotriene pathways: biochemistry, biology, and roles in disease. Chem. Rev. 111, 5866–5898, doi: 10.1021/cr200246d (2011).

3. Capdevila, J. et al. The oxidative metabolism of arachidonic acid by purified cytochromes P-450. Biochem. Biophys. Res. Commun. 101, 1357–1363 (1981).

4. Spector, A. A., Fang, X., Snyder, G. D. & Weintraub, N. L. Epoxyeicosatrienoic acids (EETs): metabolism and biochemical function. Prog. Lipid Res. 43, 55–90 (2004).

5. Rao, P. & Knaus, E. E. Evolution of nonsteroidal anti-inflammatory drugs (NSAIDs): cyclooxygenase (COX) inhibition and beyond. J. Pharm. Pharm. Sci. 11, 81s–110s (2008).

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Reorganization of innate immune cell lipid profiles by bioinspired meroterpenoids to limit inflammation;2024-05-28

2. Role of the soluble epoxide hydrolase in keratinocyte proliferation and sensitivity of skin to inflammatory stimuli;Biomedicine & Pharmacotherapy;2024-02

3. Identification of selective 5-LOX and FLAP inhibitors as novel anti-inflammatory agents by ligand-based virtual screening;European Journal of Medicinal Chemistry;2024-01

4. Novel thiazolopyridine derivatives of diflapolin as dual sEH/FLAP inhibitors with improved solubility;Bioorganic Chemistry;2023-10

5. Differential impact of 5-lipoxygenase-activating protein antagonists on the biosynthesis of leukotrienes and of specialized pro-resolving mediators;Frontiers in Pharmacology;2023-08-23